Effects of partial silencing of genes coding for enzymes involved in glycolysis and tricarboxylic acid cycle on the enterance of human fibroblasts to the S phase by Aleksandra Konieczna et al.
Konieczna et al. BMC Cell Biology  (2015) 16:16 
DOI 10.1186/s12860-015-0062-8RESEARCH ARTICLE Open AccessEffects of partial silencing of genes coding for
enzymes involved in glycolysis and tricarboxylic
acid cycle on the enterance of human fibroblasts
to the S phase
Aleksandra Konieczna†, Aneta Szczepańska†, Karolina Sawiuk, Grzegorz Węgrzyn and Robert Łyżeń*Abstract
Background: Previously published reports indicated that some enzymes of the central carbon metabolism (CCM),
particularly those involved in glycolysis and the tricarboxylic acid cycle, may contribute to regulation of DNA replication.
However, vast majority of such works was performed with the use of cancer cells, in the light of carcinogenesis. On the
other hand, recent experiments conducted on bacterial models provided evidence for the direct genetic link between
CCM and DNA replication. Therefore, we asked if silencing of genes coding for glycolytic and/or Krebs cycle enzymes
may affect the control of DNA replication in normal human fibroblasts.
Results: Particular genes coding for these enzymes were partially silenced with specific siRNAs. Such cells remained
viable. We found that silencing of certain genes resulted in either less efficient or delayed enterance to the S phase.
This concerned following genes: HK2, PFKM, TPI, GAPDH, ENO1, LDHA, CS1, ACO2, SUCLG2, SDHA, FH and MDH2.
Decreased levels of expression of HK2, GADPH, CS1, ACO2, FH and MDH2 caused also a substantial impairment in DNA
synthesis efficiency.
Conclusions: The presented results illustrate the complexity of the influence of genes coding for enzymes of glycolysis
and the tricarboxylic acid cycle on the control of DNA replication in human fibroblasts, and indicate which of them are
especially important in this process.
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DNA replication is an essential processes in every cellu-
lar organism. Its precise regulation is crucial for ad-
equate inheritance of the genetic material by daughter
cells, and thus, proper functions of cells and organisms.
The general scheme of DNA replication is common in
prokaryotic and eukaryotic cells, however, these pro-
cesses differ significantly in details. Nevertheless, it was
indicated that principles of some regulatory mechanisms
may be common, or at least similar, in both types of cells
(for reviews see [1–3]).* Correspondence: robert.lyzen@biol.ug.edu.pl
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unless otherwise stated.Apart from involvement of specific proteins dedicated
solely to control DNA replication, it appeared that en-
zymes which primary functions were ascribed to other
processes can also play important roles in the regulation
of genome duplication. Particularly, a new light on this
problem was shed by recent studies on bacterial models.
It was demonstrated that a direct link exists between
central carbon metabolism and DNA replication regula-
tion. Namely, effects of mutations in genes coding for
Bacillus subtilis primase, helicase or lagging strand DNA
polymerase could be specifically suppressed by muta-
tions in genes encoding enzymes catalyzing terminal re-
actions of glycolysis (pgk, pgm, eno, pykA) [4]. In
Escherichia coli, effects of mutations in genes coding for
the α subunit of DNA polymerase III, DNA polymerase
III β clamp, and the primase were suppressed bytral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lytic, acetate overflow and pentose-phosphate pathways
[5]. Moreover, temperature-sensitive phenotype of a mu-
tation in the dnaA gene, coding for the replication initi-
ator protein, was overcome by deletions of pta and ackA
genes, coding for enzymes comprising the acetate over-
flow mechanism [6].
Although the studies mentioned above were conducted
on bacterial models, recent analyse of previously pub-
lished reports suggested that somewhat similar
phenomenon might occur in eukaryotes. Additional roles
of enzymes catalyzing reactions of glycolysis and trica-
boxylic acid cycle were reported previously, and some of
them include regulation of transcription, DNA binding
and involvement in carcinogenesis (summarized and dis-
cussed in [7, 8]). Therefore, one might speculate that the
direct link between central carbon metabolism and DNA
replication is not restricted to bacterial cells, but could op-
erate also in eukaryotes, including humans. On the other
hand vast majority of such studies on human cells were
performed with the use of cancer cell lines. Beside many
advantages of the use of such lines, there are also draw-
backs when considering regulatory mechanisms of DNA
replication, as cancer cells have serious disturbances in
the control of this process. Moreover, most studies con-
centrated on single enzymes, thus, different kinds of ex-
periments were performed for particular genes and
proteins. Therefore, the aim of this work was to assess the
effects of silencing of genes coding for enzymes involved
in all steps of glycolysis and tricarboxylic acid cycle on
DNA replication in human non-cancer cells. As a model,
we have chosen a human dermal fibroblast cell line, as a
representative of cells that actively divide throughout the
human life, while being non-transformed.
Results
Silencing of genes coding for enzymes involved in
glycolysis and tricarboxylic acid cycle
Human dermal fibroblasts, line HDFa, were used in all
experiments. To silence the expression of genes encod-
ing enzymes involved in glycolysis and tricarboxylic acid
cycle, specific siRNAs were employed. Following genes
were subjected to silencing: HK2 (coding for hexokinase
2), GPI (coding for phosphoglucose isomerase), PFKM
(coding for phosphofructokinase M), ALDOA (coding
for diphosphate aldolase A), TPI1 (coding for triosepho-
sphate isomerase), GAPDH (coding for glyceraldehyde
3-phosphate dehydrogenase), PGK1 (coding for 3-
phosphoglycerate kinase 1), PGAM1 (coding for phos-
phoglycerate mutase 1), ENO1 (coding for α-enolase),
PKM (coding for pyruvate kinase M), LDHA (coding for
lactate dehydrogenase A), CS1 (coding for citrate syn-
thase 1), ACO2 (coding for aconitase 2), IDH2 (coding for
isocitrate dehydrogenase 2), IDH3B (coding for isocitratedehydrogenase 3B), OGDH (coding for α-ketoglutarate de-
hydrogenase), SUCLG2 (coding for GDP-forming
succinyl-CoA synthetase 2), SDHA (succinate dehrydro-
genase complex, subunit A), FH (coding for fumarase)
and MDH2 (coding for malate dehydrogenase 2).
Particular siRNAs caused various inhibition of expres-
sion of specific genes. The levels of different transcripts
were from about 70 % to less than 10 %, relative to the
control (non-treated) cells (Fig. 1). Nevertheless, the cells
remained viable, with little or moderate effects of the
treatment on the number of alive cells in the culture. The
most pronounced effects were observed for silencing of
GAPDH and FH genes, where 60 % of cells survived
siRNA-mediated expression impairment (Fig. 2).
Enterance to the S phase following gene silencing
The time and efficiency of the enterance of the cells to the
S phase following silencing of expression of particular
genes were estimated. Two types of effects were observed
in cells treated with siRNAs impairing expression of some
genes, less efficient or delayed enterance to S phase. When
genes coding for enzymes catalyzing reactions of glycolysis
were silenced, the less efficient enterance in the S phase,
as measured by the percentage of cells in this phase, was
observed for fibroblasts with impaired expression of HK2,
PFKM, TPI, GAPDH and LDHA, with the most pro-
nounced effect in the case of GAPDH (Fig. 3). Delayed
enterance in the S phase, with a similar fraction of cells
entering this phase, was observed in fibroblasts with si-
lenced the ENO1 gene (Fig. 3). Analysis of other phases of
the cell cycle under these conditions is presented as add-
itional data [Additional file 1 and 2].
When the tricarboxylic acid cycle genes were silenced,
less efficient enterance to the S phase was observed in
cells with impaired expression of CS1, ACO2, SDHA and
FH, with the most pronounced effects in the case of ACO2
and FH, and the delayed enterance occurred in fibroblasts
with silenced SUCLG2 and MDH2 genes (Fig. 4). Analysis
of other phases of the cell cycle under these conditions is
presented as additional data [Additional file 3 and 4].
DNA synthesis in cells with silenced genes
The results described in the preceding subsection indi-
cated that silencing of several genes coding for enzymes
involved in glycolysis and tricarboxylic acids had signifi-
cant effects on the enterance of human fibroblasts in the
S phase. Less effective or delayed enterance of cells in
the S phase should imply impairment in DNA replica-
tion. To test if DNA synthesis is affected in fibroblasts
with assessed genes, we have measured rates of incorpor-
ation of bromodeoxyuridine (BrdU) in synchronized cell
cultures. In most cases, impairment of DNA synthesis was
negligible if any. However, silencing of HK2, GADPH,
CS1, ACO2, FH and MDH2 resulted in significantly less
Fig. 1 Levels of mRNAs of genes coding for glycolytic and tricarboxylic acid cycle enzymes in human dermal fibroblast cells treated with siRNAs.
Cells were seeded in 6-well plates, and transfected with siRNAs. After 72 h incubation, total RNA was purified and the level of mRNA was estimated by
qPCR analysis. Presented results are mean values from at least three independent experiments, with error bars indicating SD. In each experiment, mRNA
level measured in untreated cells was used as a control value (100 %, dashed line). In all experiments, statistically significant differences (p < 0.05 in the
t-test) were found relative to the control
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(Fig. 5). Since effects on enterance to S phase were ob-
served in cells with impairment expression of the same
genes, the results of measurement of DNA synthesis effi-
ciency corroborate the conclusion made on the basis of
those experiments.
Discussion
A direct link between central carbon metabolism and
DNA replication has been demonstrated recently in pro-
karyotic cells (summarized in [1, 9]). Analysis of previ-
ously published data led to the hypothesis that enzymes ofFig. 2 Viability of human dermal fibroblasts after silencing of genes coding
in 6-well plates, transfected with siRNAs and synchronized. Following wash
results are mean values from at least three independent experiments, with
untreated cells was used as a control value (100 %, dashed line). Statisticallcentral carbon metabolism may also be involved in the
regulation of DNA replication [7, 8]. However, particu-
lar previous reports were usually focused on single en-
zymes. Moreover, vast majority of works on human cells
were performed with cancer-derived cell lines, which
may have serious drawbacks when studying the DNA
replication control. Therefore, we have performed a
complex study, in which expression of genes coding for
enzymes involved in all steps of glycolysis and tricarb-
oxylic acid cycle were silenced with the use of specific
siRNAs. Interestingly, we found that silencing of certain
genes resulted in either less efficient or delayedfor glycolytic and tricarboxylic acid cycle enzymes. Cells were seeded
ing, the cells were collected and analyzed by flow cytometry. Presented
error bars indicating SD. In each experiment, mRNA level measured in
y significant differences relative to the control are indicated by asterisks
Fig. 3 Effects of siRNA-mediated silencing of glycolityc genes on enterance of cells in S phase. Cells were seeded on Petri dishes, transfected with
siRNA specific for indicated gene (□) and synchronized. Analogous experiments without siRNA were treated as controls (■). After cell cycle releasing,
the cells were collected every two hours, starting from 14 h, and analyzed by flow cytometry. Presented results are mean values from at least
three independent experiments, with error bars indicating SD. Statistically significant differences relative to the control are indicated by asterisks
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genes: HK2, PFKM, TPI, GAPDH, ENO1, LDHA, CS1,
ACO2, SUCLG2, SDHA, FH and MDH2. Decreased
levels of expression of HK2, GADPH, CS1, ACO2, FHand MDH2 caused also a substantial impairment in
DNA synthesis efficiency. These effects, with indicated
genes’ products in the metabolic pathways, are summa-
rized schematically in Fig. 6.
Fig. 4 Effects of siRNA-mediated silencing of tricarboxylic acid cycle genes on enterance of cells in S phase. Cells were seeded on Petri dishes,
transfected with siRNA specific for indicated gene (□) and synchronized. Analogous experiments without siRNA were treated as controls (■). After
cell cycle releasing, the cells were collected every two hours, starting from 14 h, and analyzed by flow cytometry. Presented results are mean values from
at least three independent experiments, with error bars indicating SD. Statistically significant differences relative to the control are indicated by asterisks
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olism has a significant direct influence on the regulation
of DNA replication through particular enzymes. At this
stage of our knowledge it is impossible to deduce a spe-
cific mechanism by which these enzymes may link the
metabolism to DNA synthesis. However, there are some
insights from previous works, summarized below, which
might shed some light on this phenomenon.
Impaired expression of HK2, coding for hexokinase 2,
in cancer-associated fibroblasts (CAF) resulted in a G1
phase cell cycle arrest [10]. Moreover, decreasing of HK2
expression in laryngeal squamous cell carcinoma (LSCC)
reduced proliferation and cell viability by increasing G0-
G1 ratio and apoptosis [11]. Our results, indicating a de-
creased efficiency of the enterance to S phase aftersilencing of HK2, are compatible with those observa-
tions. One of isoenzymes of phosphofructokinase, was
reported as a metabolic effector involved in the connec-
tion between glycolysis, cell proliferation and transform-
ation [12]. In fact, we also observed an impairment in
DNA synthesis when PFKM expression was down-
regulated. Moreover, depletion of GAPDH with RNA
interference in human lung carcinoma A549 and UO31
cells stopped cell proliferation, and induced cell cycle ar-
rest in G1 phase [13], which is in accordance to severe
inhibition of the enterance into S phase reported here.
Enolase could bind to specific DNA sequences and was
found in nuclei of various cell types [14],[15]. Silencing
of the ENO1 gene by siRNA inhibited the proliferation
of the HCC cell line, which was accompanied by a
Fig. 5 DNA synthesis in human dermal fibroblasts treated with siRNAs. Following siRNA trasfection and synchronization, cells were labeled with
BrdU for 24 h. Then, the cells were fixed, and incubated with anti-BrdU antibodies. BrdU incorporation was quantified by a colorimetric reaction
(absorbance at 460 nm). Presented results are mean values from at least three independent experiments, with error bars indicating SD. In each
experiment, DNA synthesis level measured in untreated cells was used as a control value (100 %, dashed line). Statistically significant differences
relative to the control are indicated by asterisks
Fig. 6 The scheme of glycolysis and the tricarboxylic acid cycle, with indicated enzymes which impaired production, due to silencing of corresponding
genes, resulted in less efficient (marked in red bold font) or delayed (marked in blue bold font) enterance of human dermal fibroblasts to the S phase.
Abbreviations: ACO - aconitase; ALDO - fructose-bisphosphate aldolase; CS - citrate synthase; ENO - enolase; FH - fumarase; GAPDH - glyceraldehyde
phosphate dehydrogenase; GPI - phosphoglucose isomerase; HK - hexokinase; IDH - isocitrate dehydrogenase; LDH - lactate dehydrogenase; MDH - malate
dehydrogenase; OGDH - α-ketoglutarate dehydrogenase; PC - pyruvate carboxylase; PDH - puryvate dehydrogenase; PFK - phosphofructokinase;
PGK - phosphoglycerate kinase; PGAM - phosphoglycerate mutase; PKM - pyruvate kinase; SCS - succinyl-CoA synthetase; SDH - succinate dehydrogenase;
TPI - triosephosphate isomerase. Abbreviations of metabolite names are as follows: 1,3BPG - 1,3-bisphosphoglycerate; 2PG - 2-phosphoglycerate;
3-P-G - 3-phosphoglycerate; AC-CoA - Acetyl-CoA; CIT - citrate; DHAP - dihydroxyacetone phosphate; F1,6BP - fructose 1,6-bisphosphate; F6P - fructose
6-phosphate; FUM - fumarate; G6P - glucose 6-phosphate; GADP - glyceraldehyde 3-phosphate; ICT - isocitrate; MAL - malate; OXA - oxaloacetate;
PEP - phosphoenolpyruvate; Pyr - pyruvate; SUC - succinate; SUC-CoA - α-ketoglutarate
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cycle [16]. Downregulation of ENO1 by siRNA inhibited
cell migration and invasion in glioma cells. Reduction of
ENO1 activity significantly decreased the phosphoryl-
ation of PI3K and Akt and reduced level of E-Cadherin,
Cyclin D1, and p-Rb [17]. Thus, it is intriguing that we
have observed a delay in the enterance to S phase in
cells with the partially silenced ENO1 gene. Lactate de-
hydrogenase was found in nuclei of mammalian cells,
and its possible function in DNA replication was sug-
gested [18],[19]. Knocking down the expression of
LDHA in human hepatocellular carcinoma cells and
pancreatic cancer cells inhibited cell growth dramatically
by activation of the apoptosis pathway [20], [21],[22]. In
human fibroblasts with the silenced LDHA gene, we
have observed a decreased number of cells entering the
S phase. In cancer cell lines, HeLa and SiHa, a decrease
in expression of the CS1 gene was proportional to the
malignancy, but this effect appeared to be linked to dis-
turbed p53 function [23]. On the other hand CS knock-
down in human ovarian adenocarcinoma cell line
SKOV3 and A2780 cells resulted in dysregulation of cell
metabolism and downregulation of proliferation by de-
creasing phosphorylation of the extracellular signal-
regulated kinase (ERK), a key component in the control
of cell growth, and increasing of CASP7 encoded Cas-
pase 7 involved in the caspase activation cascade respon-
sible for the execution of apoptosis [11]. In accordance
to those reports, some negative effects on DNA replica-
tion in human fibroblasts with impaired expression of
CS1 were found in this work. Silencing of expression of
the SDHA gene resulted in a decrease of growth rate of
cancer cells [24]. In our experiments, such silencing
caused less efficient enterance into S phase. Finally, fu-
marase has been proposed to act as a tumor suppressor
[25]. Knockdown of FH and SDHA/B genes in HeLA
cells led to accumulation of fumarate and succinate,
which act as competitive inhibitors of multiple α-
ketoglutarate-dependent dioxygenases, including histone
and DNA demethylases [26]. Inactivation of histone
demethylases, promotes G1 cell-cycle arrest, and in-
duces genes for differentiation by selectively modulat-
ing the methylation states of histone H3 at lysines 4
(H3K4) and 9 (H3K9) [27]. In human fibroblasts, we
have observed a severe inhibition of the cell cycle at
the stage of the S phase enterance under conditions
of partial FH silencing.
The advantage of this study, in relation to previous
works, discussed above in comparison to our work, is
that the results presented here were obtained in the
same cell line of human dermal fibroblasts. Generally,
we have observed two types of the effects of silencing of
particular genes: less efficient or delayed enterance to
the S phase. Furthermore, reduction in efficiency inDNA synthesis was demonstrated in cells deficient in ex-
pression of the same genes as in the case of the less effi-
cient enterance to the S phase. Therefore, the studies
reported here provide a complex picture of the effects of a
decreased levels of expression of the central carbon me-
tabolism genes on DNA replication in human fibroblasts.
In the light of the general mechanisms of glycolysis, our
results indicating different effects caused by silencing of
GPI or GAPDH gene, an increase or severe decrease in ef-
ficiency of enterance into S phase, respectively, may be
considered as intriguing. Glycolysis is a multi-step process,
and each of the steps is performed either by one or mul-
tiple enzymes (isoforms). In contrast to the other steps,
the second and sixth steps are catalyzed by the only one
enzyme, GPI and GAPDH, respectively. GPI is the only
enzyme catalyzing the second step of glycolysis, perform-
ing the conversion of glucose-6-phosphate to fructose-6-
phosphate. Similarly, GAPDH is another bottleneck, the
only enzyme catalyzing the sixth glycolytic step (except
GAPDHS, a testis-specific isoform of GAPDH). Thus,
metabolic effects (glycolysis down-regulation) of silencing
GPI and GAPDH genes might be expected to be similar.
Contrary to such presumption, the observed effects on cell
proliferation have been completely different when either
GPI or GAPDH were silenced with siRNA, as indicated
above. The dramatic decrease in the fraction of cells enter-
ing to the S phase, as well as in viable cells count,
when expression of GAPDH is impaired, indicates that
GAPDH plays not only metabolic roles but also may be
directly involved in the regulation of cell proliferation.
In fact, despite the lack of direct proofs of GAPDH
involvement in DNA replication and cell proliferation,
this enzyme is considered as a potential cancer therapeutic
target [28].
Although we are not able to propose specific mecha-
nism(s) by which enzymes of glycolysis and tricarboxylic
acid cycle can influence the regulation of DNA replica-
tion, it appears that the link between these metabolic
pathways and the control of cell cycle, particularly DNA
synthesis, is important. Plausibly, this link is direct
through certain enzymes. Alternatively, metabolites
which accumulate due to impairment of enzymatic activ-
ities might acts as signals in the regulatory processes as
it was shown for fumarate and succinate [26]. Irrespect-
ive of the detailed molecular mechanisms, it seems that
DNA replication in human cells can be specifically regu-
lated in response to the metabolic status of the cell, and
there are several steps in glycolysis and tricarboxylic acid
cycle which efficiency could be sensed by the DNA repli-
cation machinery. Finally, it is interesting that the direct
links between central carbon metabolism and DNA rep-
lication appear to exist in both eukaryotic and prokary-
otic systems (for discussions see [1, 7, 9]). Therefore,
one might speculate that sensing the metabolic status of
Table 1 Primers used for real-time qPCR to estimate mRNA





HK2 F: 5’- CGAGGTCTGAGCAAGGAGAC GUSB, HPRT
R: 5’- GTCCGGGGTAGCACACAC
GPI F: 5’- GCTTTGCTGCGTACTTCCA TBP, ACTB
R: 5’- GTCCACACGGGTTCCAGA
PFKM F: 5’- GCCATCAGCCTTTGACAGA GUSB, HPRT
R: 5’- CTCCAAAAGTGCCATCACTG
ALDOA F: 5’- TCCTCTAGCCCGTGGAATCR: 5’-
AAGACGATGGCAGGGATG
TBP, ACTB
TPI1 F: 5’- GCTCAGAGCACCCGTATCAT GUSB, HPRT
R: 5’- CACAAGGAAGCCATCCACAT
GAPDH F: 5’- ACGGGAAGCTTGTCATCAAT TBP, ACTB
R: 5’- CATCGCCCCACTTGATTTT
PGK1 F: 5’- CTCATGGATGAGGTGGTGAA TBP, ACTB
R: 5’- CACAGCAAGTGGCAGTGTCT
PGAM1 F: 5’- AGGCGCTCCTATGATGTCC TBP, ACTB
R: 5’- CGATCCTTACTGATGTTGCTGT
ENO1 F: 5’- CAACCAGCTCCTCAGAATTGA GUSB, HPRT
R: 5’- GCCAAGGGGTTTCTGAAGTT
PKM F: 5’- ACCCTCCACTCAGCTGTCC TBP, ACTB
R: 5’- CCTGGAGGTGCTGCAGTAGT
LDHA F: 5’- GGTGGATGTTTACCGTGTGTT TBP, ACTB
R: 5’- TGGATCCCAGGATGTGACTC
CS F: 5’- TCCGACCCTTACCTGTCCTT TBP, ACTB
R: 5’- ACTTCCTGATTTGCCAGTCC
ACO2 F: 5’- AGATTGTGTATGGACACCTGGA HPRT, GUSB
R: 5’- TACGACTTGCCTCGCTCAAT
IDH2 F: 5’- CCATCATCTGCAAAAACATCC HPRT, GUSB
R: 5’- CCAATGGTGATGGGCTTG
IDH3B F: 5’- GCCCAATCTCTATGGGAACA TBP, ACTB
R: 5’- CAGGGACCACACCAGCTC
OGDH F: 5’- AGAGTCCCCTTCCCCTGAG TBP, ACTB
R: 5’- GCTTCTACCAGGGACTGTCC
SUCLG2 F: 5’- AGCCAGCCAACTTCTTGGA TBP, ACTB
R: 5’- GGATGGCTTCAACCTTAGGA
SDHA F: 5’- CAGCACAGGGAGGAATCAAT HPRT, GUSB
R: 5’- CTGCTCCGTCATGTAGTGGA
FH F: 5’- TGAATGTTTTCAAGCCAATGAT HPRT, GUSB
R: 5’- CCACCACGCAGTTTTCTGTA
MDH2 F: 5’- CAGGACCAGCTGACAGCAC TBP, ACTB
R: 5’- AGCCTGCTCCGGCTTTAG
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tionarily old phenomenon, which can be of particular
importance for cell physiology.
Conclusions
Partial silencing of genes coding for enzymes catalyzing
particular reactions of glycolysis and the tricarboxylic acid
cycle illustrated the complexity of the influence of central
carbon metabolism on the control of DNA replication in
human fibroblasts. Following genes appear to be especially
important in this process: HK2, PFKM, TPI, GAPDH,
ENO1, LDHA, CS1, ACO2, SUCLG2, SDHA, FH and
MDH2. These results, together with previously published
reports describing the link between central carbon metab-
olism and DNA replication in bacteria, might suggest that
sensing the metabolic status of the cell by the cellular rep-
lication factory is an evolutionarily old phenomenon,
which can be of particular importance for cell physiology.
Methods
Cell cultures
The Human Dermal Fibroblasts, adult HDFa (Cascade
Biologics) were cultured in a 5 % CO2 humidified atmos-
phere at 37 °C in Dulbecco’s Modified Eagle’s Medium
(DMEM; GIBCO) supplemented with 10 % fetal bovine
serum (FBS; GIBCO).
Cell cycle synchronization
HDFa were subjected to gradual serum deprivation: 5 %
FBS for 6 h, 1 % FBS for 6 h and DMEM without FBS
for 12 h. The DNA content was analyzed by MuseTM
Cell Analyzer. DNA histogram revealed that over 90 %
of HDFa were inhibited at G0/G1 phase after starvation.
Then, the cells were released into cell cycle by addition
of 10 % serum.
RNA interference
Silencer® Select siRNAs (Small interfering RNAs) were pur-
chased from Life Technology/Ambion. Transfections were
performed with HiPerFect Transfection Reagent (Qiagen)
as specified by the manufacturer. All targeted enzymes
showed maximal knockdown 72 h after transfection.
mRNA quantitation
1 × 105 cells were seeded in 6-well plates. 72 h after
transfection total RNA was extracted with High Pure
RNA Isolation Kit (Roche Diagnostics). The cDNA for
PCR template was generated by using Transcriptor First
Strand cDNA Synthesis Kit (Roche Diagnostics) accord-
ing to the manufacturer's protocol. Real-time PCR was
performed on a LightCyler system 0.2 (Roche Applied
Science) by using LightCycler® TaqMan Master Kit. The
sequences of primers and housekeeping genes for
normalization are presented in Table 1. The choice of
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expression level of the tested gene.
Cell cycle analysis
Cell cycle analysis was performed utilizing Muse™ Cell
Analyzer (Merck Millipore) and following manufac-
turer’s instruction. Briefly, after the siRNAs transfection
and subsequent cell cycle synchronization, the cells were
washed with PBS and fixed in 70 % ice-cold ethanol.
Cells were collected every two hours starting from 14 h
after cell cycle releasing by addition of 10 % serum. After
staining with Muse™ Cell Cycle Reagent, the cells were
processed for cell cycle analysis.
Cell counting and viability
Cell counting and viability was determined by using the
Muse® Count & Viability Assay Kit (Merck Millipore),
according to the manufacturer’s instruction. Briefly, after
the transfection with siRNAs, and subsequent cell cycle
synchronization, the cells were collected and incubated
with Muse™ Count &Viability Reagent. The number of
viable cells were counted by using Muse™ Cell Analyzer
(Merck Millipore).
Proliferation assay
Cell proliferation was determined by using the Cell Pro-
liferation ELISA, BrdU (colorimetric) (Roche Diagnos-
tics) Kit according to the manufacturer's instructions.
Briefly, cells were seeded onto 96-well plate in an
amount of 1000 cells/well. After siRNAs transfection and
subsequent synchronization, cells were labeled with BrdU
for 24 h. Then, cells were fixed, incubated with anti-BrdU
antibodies and the BrdU incorporation was quantified by
colorimetric reaction. Absorbance at 450 nm was mea-
sured by using an automated microplate reader (Wallac
1420 Multilabel Counter, Perkin Elmer).
Additional files
Below is the link to the electronic supplementary material.
Additional file 1: Figure 1. Effects of siRNA-mediated silencing of glycolityc
genes on the fraction of cells in G0/G1 phase. Cells were seeded on Petri
dishes, transfected with siRNA specific for indicated gene (□) and synchronized.
Analogous experiments without siRNA were treated as controls (■). After cell
cycle releasing, the cells were collected every two hours, starting from 14 h,
and analyzed by flow cytometry. Presented results are mean values from at
least three independent experiments, with error bars indicating SD. Statistically
significant differences relative to the control are indicated by asterisks.
Additional file 2: Figure 2. Effects of siRNA-mediated silencing of glycolityc
genes on the fraction of cells in G2/M phase. Cells were seeded on Petri dishes,
transfected with siRNA specific for indicated gene (□) and synchronized.
Analogous experiments without siRNA were treated as controls (■). After cell
cycle releasing, the cells were collected every two hours, starting from 14 h,
and analyzed by flow cytometry. Presented results are mean values from at
least three independent experiments, with error bars indicating SD. Statistically
significant differences relative to the control are indicated by asterisks.Additional file 3: Figure 3. Effects of siRNA-mediated silencing of
tricarboxylic acid cycle genes on the fraction of cells in G0/G1 phase.
Cells were seeded on Petri dishes, transfected with siRNA specific for indicated
gene (□) and synchronized. Analogous experiments without siRNA were
treated as controls (■). After cell cycle releasing, the cells were collected every
two hours, starting from 14 h, and analyzed by flow cytometry. Presented
results are mean values from at least three independent experiments, with
error bars indicating SD. Statistically significant differences relative to the
control are indicated by asterisks.
Additional file 4: Figure 4. Effects of siRNA-mediated silencing of
tricarboxylic acid cycle genes on the fraction of cells in G2/M phase.
Cells were seeded on Petri dishes, transfected with siRNA specific for
indicated gene (□) and synchronized. Analogous experiments without
siRNA were treated as controls (■). After cell cycle releasing, the cells were
collected every two hours, starting from 14 h, and analyzed by flow cytometry.
Presented results are mean values from at least three independent experiments,
with error bars indicating SD. Statistically significant differences relative to
the control are indicated by asterisks.
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